Dr. Kydd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Drive
Building 10, B2L213
Bethesda, MD 20892Phone+1 240-551-4679
Education & Training
- Florida Atlantic University Charles E. Schmidt College of MedicineResidency, Internal Medicine, 2014 - 2017
- Johns Hopkins University School of MedicineClass of 2014
Certifications & Licensure
- MD State Medical License 2020 - 2026
- DC State Medical License 2020 - 2024
- MA State Medical License 2017 - 2022
- FL State Medical License 2016 - 2018
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... Start of enrollment: 2024 Aug 01
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors Start of enrollment: 2019 May 13
Publications & Presentations
PubMed
- A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale.Nicholas Simon, Elias Chandran, Saad Atiq, Andre R Kydd, Daniel Girardi
Future Oncology. 2025-03-21 - Antibody-drug conjugates in rare genitourinary tumors: review and perspectives.Andre R Kydd, Md Shahid Sarwar, Saad Atiq, Raju Chelluri, Sandeep Gurram
Current Opinion in Oncology. 2025-03-19 - 4 citationsFinal Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal, Andre R Kydd
Journal of Clinical Oncology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: